BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 21052776)

  • 1. Radiographic patterns of relapse in glioblastoma.
    Chamberlain MC
    J Neurooncol; 2011 Jan; 101(2):319-23. PubMed ID: 21052776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glioblastoma: patterns of recurrence and efficacy of salvage treatments.
    Oh J; Sahgal A; Sanghera P; Tsao MN; Davey P; Lam K; Symons S; Aviv R; Perry JR
    Can J Neurol Sci; 2011 Jul; 38(4):621-5. PubMed ID: 21672702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy may alter the patterns of failure in patients with glioblastoma multiforme.
    Reddy K; Gaspar LE; Kavanagh BD; Chen C
    J Med Imaging Radiat Oncol; 2014 Dec; 58(6):714-21. PubMed ID: 24975917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial.
    Schaub C; Kebir S; Junold N; Hattingen E; Schäfer N; Steinbach JP; Weyerbrock A; Hau P; Goldbrunner R; Niessen M; Mack F; Stuplich M; Tzaridis T; Bähr O; Kortmann RD; Schlegel U; Schmidt-Graf F; Rohde V; Braun C; Hänel M; Sabel M; Gerlach R; Krex D; Belka C; Vatter H; Proescholdt M; Herrlinger U; Glas M
    J Cancer Res Clin Oncol; 2018 Aug; 144(8):1581-1589. PubMed ID: 29808316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial and cumulative recurrence patterns of glioblastoma after temozolomide-based chemoradiotherapy and salvage treatment: a retrospective cohort study in a single institution.
    Ogura K; Mizowaki T; Arakawa Y; Ogura M; Sakanaka K; Miyamoto S; Hiraoka M
    Radiat Oncol; 2013 Apr; 8():97. PubMed ID: 24499582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel tool to analyze MRI recurrence patterns in glioblastoma.
    Wick W; Stupp R; Beule AC; Bromberg J; Wick A; Ernemann U; Platten M; Marosi C; Mason WP; van den Bent M; Weller M; Rorden C; Karnath HO;
    Neuro Oncol; 2008 Dec; 10(6):1019-24. PubMed ID: 18676355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma.
    Lou E; Peters KB; Sumrall AL; Desjardins A; Reardon DA; Lipp ES; Herndon JE; Coan A; Bailey L; Turner S; Friedman HS; Vredenburgh JJ
    Cancer Med; 2013 Apr; 2(2):185-95. PubMed ID: 23634286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-treating fields plus chemotherapy versus chemotherapy alone for glioblastoma at first recurrence: a post hoc analysis of the EF-14 trial.
    Kesari S; Ram Z;
    CNS Oncol; 2017 Jul; 6(3):185-193. PubMed ID: 28399638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent bevacizumab and temozolomide alter the patterns of failure in radiation treatment of glioblastoma multiforme.
    Shields LB; Kadner R; Vitaz TW; Spalding AC
    Radiat Oncol; 2013 Apr; 8():101. PubMed ID: 23618500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma.
    Wick W; Chinot OL; Bendszus M; Mason W; Henriksson R; Saran F; Nishikawa R; Revil C; Kerloeguen Y; Cloughesy T
    Neuro Oncol; 2016 Oct; 18(10):1434-41. PubMed ID: 27515827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline multicentric tumors, distant recurrences and leptomeningeal dissemination predict poor survival in patients with recurrent glioblastomas receiving bevacizumab.
    Toh CH; Liau CT; Wei KC; Castillo M
    J Neurooncol; 2019 Mar; 142(1):149-159. PubMed ID: 30535596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of salvage treatment for recurrent glioblastoma.
    Kim HR; Kim KH; Kong DS; Seol HJ; Nam DH; Lim DH; Lee JI
    J Clin Neurosci; 2015 Mar; 22(3):468-73. PubMed ID: 25595963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of field strength on glioblastoma multiforme response in patients treated with the NovoTTF™-100A system.
    Turner SG; Gergel T; Wu H; Lacroix M; Toms SA
    World J Surg Oncol; 2014 May; 12():162. PubMed ID: 24884522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiographic patterns of progression with associated outcomes after bevacizumab therapy in glioblastoma patients.
    Cachia D; Elshafeey NA; Kamiya-Matsuoka C; Hatami M; Alfaro-Munoz KD; Mandel JJ; Colen R; DeGroot JF
    J Neurooncol; 2017 Oct; 135(1):75-81. PubMed ID: 28702781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nivolumab for patients with recurrent glioblastoma progressing on bevacizumab: a retrospective case series.
    Chamberlain MC; Kim BT
    J Neurooncol; 2017 Jul; 133(3):561-569. PubMed ID: 28500559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide.
    Sherriff J; Tamangani J; Senthil L; Cruickshank G; Spooner D; Jones B; Brookes C; Sanghera P
    Br J Radiol; 2013 Feb; 86(1022):20120414. PubMed ID: 23385995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide.
    Minniti G; Amelio D; Amichetti M; Salvati M; Muni R; Bozzao A; Lanzetta G; Scarpino S; Arcella A; Enrici RM
    Radiother Oncol; 2010 Dec; 97(3):377-81. PubMed ID: 20855119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns and timing of recurrence after temozolomide-based chemoradiation for glioblastoma.
    Milano MT; Okunieff P; Donatello RS; Mohile NA; Sul J; Walter KA; Korones DN
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1147-55. PubMed ID: 20207495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, Radiographic, and Pathologic Findings in Patients Undergoing Reoperation Following Radiation Therapy and Temozolomide for Newly Diagnosed Glioblastoma.
    Ellsworth S; Ye X; Grossman SA
    Am J Clin Oncol; 2017 Jun; 40(3):219-222. PubMed ID: 26491903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progression.
    Eisele G; Wick A; Eisele AC; Clément PM; Tonn J; Tabatabai G; Ochsenbein A; Schlegel U; Neyns B; Krex D; Simon M; Nikkhah G; Picard M; Stupp R; Wick W; Weller M
    J Neurooncol; 2014 Mar; 117(1):141-5. PubMed ID: 24442484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.